Organization Profile

Related Organization(s)

You just read:

OxyNov, Desjardins-Innovatech and CTS Santé join forces to revolutionize the treatment of chronic obstructive pulmonary disease, the world's fifth leading cause of death with 3 million fatalities per year

News provided by

Desjardins-Innovatech

May 10, 2017, 15:33 ET